Related Experiment Video
Updated: Jul 9, 2026
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies
Glaucia H Braun1, Daniel M M Jorge, Henrique P Ramos
1Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.
Abstract:
Monoamine oxidase is a flavoenzyme bound to the mitochondrial outer membranes of the cells, which is responsible for the oxidative deamination of neurotransmitter and dietary amines. It has two distinct isozymic forms, designated MAO-A and MAO-B, each displaying different substrate and inhibitor specificities. They are the well-known targets for antidepressant, Parkinson's disease, and neuroprotective drugs. Elucidation of the x-ray crystallographic structure of MAO-B has opened the way for the molecular modeling studies. In this work we have used molecular modeling, density functional theory with correlation, virtual screening, flexible docking, molecular dynamics, ADMET predictions, and molecular interaction field studies in order to design new molecules with potential higher selectivity and enzymatic inhibitory activity over MAO-B.
Insights
Researchers designed novel molecules targeting monoamine oxidase-B (MAO-B) using computational methods. These new compounds show potential for higher selectivity and inhibitory activity, aiding drug development for neurological disorders.
Area of Science:
- Biochemistry
- Computational Chemistry
- Neuroscience
Background:
- Monoamine oxidase (MAO) enzymes, specifically MAO-A and MAO-B, are crucial for amine metabolism.
- MAO-A and MAO-B are key targets for drugs treating depression, Parkinson's disease, and neurodegenerative conditions.
- The availability of MAO-B crystal structures enables structure-based drug design.
Purpose of the Study:
- To design novel molecules with enhanced selectivity and inhibitory activity against MAO-B.
- To leverage advanced computational techniques for rational drug design targeting MAO-B.
- To explore structure-activity relationships for MAO-B inhibitors.
Main Methods:
- Molecular modeling and simulation.
- Density Functional Theory (DFT) with correlation.
- Virtual screening, flexible docking, and molecular dynamics.
- ADMET predictions and molecular interaction field (MIF) studies.
Main Results:
- Identification of potential lead compounds with predicted high selectivity and inhibitory potency for MAO-B.
- In silico validation of designed molecules through various computational analyses.
- Detailed analysis of molecular interactions guiding further optimization.
Conclusions:
- Computational approaches are effective for designing targeted MAO-B inhibitors.
- The designed molecules represent promising candidates for further preclinical development.
- This study provides a foundation for developing next-generation MAO-B therapeutics.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
02:04Protein-protein Interfaces